Who owns CENTESSA PHARMACEUTICALS PLC?
- Ticker: CNTA
- CUSIP Number: 152309100
Tip: Access positions for across all investors
Analyze quarterly positions in Centessa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Centessa Pharmaceuticals stock
Who bought or sold CENTESSA PHARMACEUTICALS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Medicxi Ventures Management | 20M | $319M | 0% | Sep 2024 |
|
| General Atlantic | 9.7M | $155M | 0% | Sep 2024 |
|
| Perceptive Advisors | 6.3M | $101M | 60% | Sep 2024 |
|
| First Light Asset Management | 5.9M | $95M | 24% | Sep 2024 |
|
| EcoR1 Capital | 5.7M | $52M | 2% | Jun 2024 |
|
| T. Rowe Price Associates | 4.7M | $75M | 33% | Sep 2024 |
|
| Vida Ventures Advisors | 3.9M | $63M | 0% | Sep 2024 |
|
| T. Rowe Price Investment Management | 3.6M | $57M | 326% | Sep 2024 |
|
| Siren | 3.3M | $52M | 100% | Sep 2024 |
|
| TCG Crossover Management | 2.9M | $26M | 42% | Jun 2024 |
|
| Point72 Asset Management | 2.7M | $43M | 54% | Sep 2024 |
|
| Franklin Resources | 2.3M | $38M | 99% | Sep 2024 |
|
| Driehaus Capital Management | 2.2M | $35M | 3% | Sep 2024 |
|
| Avidity Partners Management | 2.1M | $34M | 100% | Sep 2024 |
|
| Morgan Stanley | 2.1M | $19M | -4% | Jun 2024 |
|
| Octagon Capital Advisors | 2.0M | $32M | -14% | Sep 2024 |
|
| Farallon Capital Management | 2.0M | $18M | 438% | Jun 2024 |
|
| Cormorant Asset Management | 1.6M | $15M | 187% | Jun 2024 |
|
| Commodore Capital | 1.4M | $22M | 100% | Sep 2024 |
|
| 5AM Venture Management | 1.3M | $21M | 3% | Sep 2024 |
|
| Baker Bros. Advisors | 1.2M | $20M | 123% | Sep 2024 |
|
| American Century Companies | 1.1M | $18M | 22% | Sep 2024 |
|
| Balyasny Asset Management | 1.0M | $9.2M | 302% | Jun 2024 |
|
| Affinity Asset Advisors | 966k | $15M | -15% | Sep 2024 |
|
| Tanager Wealth Management | 696k | $11M | 0% | Sep 2024 |
|
| Citadel Advisors | 623k | $10M | 1067% | Sep 2024 |
|
| BlackRock | 560k | $8.9M | 100% | Sep 2024 |
|
| TD Asset Management | 559k | $8.8M | 74% | Sep 2024 |
|
| Woodline Partners | 516k | $8.3M | 318% | Sep 2024 |
|
| Nantahala Capital Management | 513k | $8.2M | 14% | Sep 2024 |
|
| BlackRock | 465k | $4.2M | 21% | Jun 2024 |
|
| Platinum Investment Mangement | 430k | $6.9M | -11% | Sep 2024 |
|
| Tang Capital Management | 400k | $6.4M | 100% | Sep 2024 |
|
| Bank of America Corporation | 313k | $5.0M | 328% | Sep 2024 |
|
| Lord, Abbett & Co | 269k | $4.3M | 100% | Sep 2024 |
|
| Partner Fund Management | 269k | $4.3M | -58% | Sep 2024 |
|
| Blue Owl Capital Holdings | 255k | $4.1M | 100% | Sep 2024 |
|
| Renaissance Technologies | 210k | $3.4M | 21% | Sep 2024 |
|
| Marshall Wace | 181k | $2.9M | -20% | Sep 2024 |
|
| Fred Alger Management | 178k | $2.8M | 1515% | Sep 2024 |
|
| Jane Street | 177k | $2.8M | 100% | Sep 2024 |
|
| Trexquant Investment | 171k | $2.7M | 291% | Sep 2024 |
|
| HighMark Wealth Management | 167k | $2.7M | 80% | Sep 2024 |
|
| Monashee Investment Management | 161k | $2.6M | 56% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 141k | $1.3M | 30% | Jun 2024 |
|
| Exome Asset Management | 138k | $2.2M | -50% | Sep 2024 |
|
| Jpmorgan Chase & Co | 136k | $2.2M | 1969% | Sep 2024 |
|
| Cubist Systematic Strategies | 134k | $2.1M | 414% | Sep 2024 |
|
| DAFNA Capital Management | 120k | $1.9M | -2% | Sep 2024 |
|
| GSA Capital Partners | 94k | $1.5M | 66% | Sep 2024 |
|
| Stempoint Capital | 84k | $1.3M | 100% | Sep 2024 |
|
| Artia Global Partners | 80k | $1.3M | 100% | Sep 2024 |
|
| Ensign Peak Advisors | 79k | $1.3M | 100% | Sep 2024 |
|
| Geode Capital Management | 57k | $905k | 69% | Sep 2024 |
|
| Two Sigma Investments | 52k | $468k | -34% | Jun 2024 |
|
| Susquehanna International | 51k | $822k | 100% | Sep 2024 |
|
| Jump Financial | 49k | $786k | 101% | Sep 2024 |
|
| D. E. Shaw & Co | 48k | $769k | 100% | Sep 2024 |
|
| Rathbones Brothers | 31k | $283k | 0% | Jun 2024 |
|
| Lynx1 Capital Management | 17k | $278k | 0% | Sep 2024 |
|
| Atria Investments | 17k | $274k | 7% | Sep 2024 |
|
| Harbour Capital Advisors | 17k | $259k | 100% | Sep 2024 |
|
| Citigroup | 14k | $225k | 1048% | Sep 2024 |
|
| EntryPoint Capital | 14k | $218k | 68% | Sep 2024 |
|
| China Universal Asset Management | 14k | $217k | 100% | Sep 2024 |
|
| Quarry | 9.6k | $87k | 48% | Jun 2024 |
|
| Royal Bank of Canada | 6.3k | $103k | 462% | Sep 2024 |
|
| Sandia Investment Management | 5.0k | $80k | -50% | Sep 2024 |
|
| Advisors Preferred | 4.6k | $78k | 100% | Sep 2024 |
|
| Qube Research & Technologies | 3.5k | $32k | -61% | Jun 2024 |
|
| GAMMA Investing | 3.0k | $48k | 103% | Sep 2024 |
|
| Mirae Asset Global Investments | 2.6k | $40k | 48% | Sep 2024 |
|
| Zurcher Kantonalbank | 2.2k | $35k | -2% | Sep 2024 |
|
| Golden State Equity Partners | 1.7k | $27k | 100% | Sep 2024 |
|
| Tower Research Capital | 1.3k | $12k | 29% | Jun 2024 |
|
| Ronald Blue Trust | 1.0k | $9.2k | 43% | Sep 2024 |
|
| Adirondack Trust | 925.00 | $15k | 0% | Sep 2024 |
|
| Global Retirement Partners | 700.00 | $11k | 0% | Sep 2024 |
|
| Barclays | 350.00 | $6.0k | 100% | Sep 2024 |
|
| Daiwa Securities Group | 211.00 | $3.0k | 0% | Sep 2024 |
|
| Nbc Securities | 138.00 | $2.0k | 0% | Sep 2024 |
|
| Simplex Trading | 108.00 | $1.0k | 100% | Sep 2024 |
|
| Caldwell Sutter Capital | 86.00 | $1.4k | 0% | Sep 2024 |
|
Who sold out of Centessa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Artal Group | Jun 2024 | 2.1M | $19M |
| ExodusPoint Capital Management | Mar 2024 | 379k | $4.3M |
| Goldman Sachs Group | Mar 2024 | 55k | $622k |
| Millennium Management | Jun 2024 | 50k | $447k |
| XTX Topco | Jun 2024 | 16k | $148k |
| Schonfeld Strategic Advisors | Jun 2024 | 12k | $111k |
| State of Tennessee, Treasury Department | Mar 2024 | 5.8k | $66k |
| Wells Fargo & Company | Jun 2024 | 520.00 | $4.7k |
| Advisor Group Holdings | Mar 2024 | 300.00 | $3.4k |